SARS-CoV-2 antibody neutralization evaluation against variants and diagnostic and therapeutic applications with Kumamoto University

A theme aimed at applying antibodies against the SARS-CoV-2 spike protein, obtained on an ongoing basis through joint research with Kumamoto University, to diagnostic and therapeutic products by evaluating their neutralizing activity against viruses, including variants.